Private

Puma Exploration Closes $625,000 Charity Flow-Through Private Placement

Retrieved on: 
Thursday, March 28, 2024
Indian stock exchange, Income Tax Act, TSX Venture Exchange, Private, Acceleration, PUMA, TSX, CFT, OTCQB, Security (finance)

RIMOUSKI, Québec, March 28, 2024 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) announces that it has closed a non-brokered placement (the “CFT Private Placement”) consisting of 5,000,000 Charity flow-through units (the “CFT Units”) at $0.125 per CFT Unit for gross proceeds of C$625,000.

Key Points: 
  • RIMOUSKI, Québec, March 28, 2024 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) announces that it has closed a non-brokered placement (the “CFT Private Placement”) consisting of 5,000,000 Charity flow-through units (the “CFT Units”) at $0.125 per CFT Unit for gross proceeds of C$625,000.
  • In connection with the closing of the private placement offering, the Company paid NO cash finder's fees NOR finder warrants.
  • All securities issued in connection with the private placement are subject to a four-month-and-one-day hold period expiring on July 29, 2024.
  • The private placement has received conditional approval from the TSX Venture Exchange.

Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules

Retrieved on: 
Wednesday, March 27, 2024
Common stock, Private, Exercise, Form, Telephone, Common, Sale, Attention, Prospectus, Form S-3, P.C, Security (finance)

In a concurrent private placement, the Company also agreed to sell to the same investors, common warrants (“Common Warrants”).

Key Points: 
  • In a concurrent private placement, the Company also agreed to sell to the same investors, common warrants (“Common Warrants”).
  • Aggregate gross proceeds to the Company from both transactions are expected to be approximately $2.76 million, the maximum availability under the effective shelf registration statement.
  • The Common Warrants are exercisable immediately subject to registration and expire 5 years after the initial issuance date.
  • The registered direct offering is being made pursuant to an effective shelf registration statement on Form S-3 (No.

Li-FT Closes $10.1 Million In Flow-Through Share Financings

Retrieved on: 
Wednesday, March 27, 2024
Lithium, Public, Income Tax Act, Private, Sale, Regulation, WIRE, Person, Agent, NOT, Legislation, NEWS, Prospectus, Security (finance)

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce it has closed the previously announced marketed public offering (the “Public Offering”) of 1,179,500 common shares of the Company issued on a “flow-through” basis (each a “Flow-Through Share”) at a price of $6.05 per Flow-Through Share. The Public Offering generated aggregate gross proceeds of $7,135,975. The Flow-Through Shares will qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada)).

Key Points: 
  • The Flow-Through Shares will qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada)).
  • The Public Offering was led by Canaccord Genuity Corp. on behalf of a syndicate of agents, including SCP Resource Finance LP.
  • The Base Shelf Prospectus and the Prospectus Supplement are available under the Company’s profile on SEDAR+ at www.sedarplus.ca.
  • The Private Placement Flow-Through Shares will qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada)).

Alamos Gold Announces Friendly Acquisition of Argonaut Gold

Retrieved on: 
Wednesday, March 27, 2024
La Colorada, Immediate, Private, Growth, Agreement, Webcast, Par value, AGI, Gold, Torys, Scotiabank, Toronto Stock Exchange, Alamos Gold, Life, TSX, Mineral, Arrangement, Transaction

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (“Alamos”) (TSX:AGI; NYSE:AGI) and Argonaut Gold Inc. (“Argonaut”) (TSX:AR) are pleased to announce that they have entered into a definitive agreement (the “Agreement”) whereby Alamos will acquire all of the issued and outstanding shares of Argonaut pursuant to a court approved plan of arrangement (the “Transaction”).

Key Points: 
  • TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (“Alamos”) (TSX:AGI; NYSE:AGI) and Argonaut Gold Inc. (“Argonaut”) (TSX:AR) are pleased to announce that they have entered into a definitive agreement (the “Agreement”) whereby Alamos will acquire all of the issued and outstanding shares of Argonaut pursuant to a court approved plan of arrangement (the “Transaction”).
  • As part of the Transaction, Alamos will acquire Argonaut’s Magino mine, located adjacent to its Island Gold mine in Ontario, Canada.
  • Under the terms of the Agreement, each Argonaut common share outstanding will be exchanged for 0.0185 Alamos common shares and 1 share of SpinCo2 (the “Exchange Ratio”).
  • Upon completion of the Transaction, existing Alamos and Argonaut shareholders will own approximately 95% and 5% of the pro forma company, respectively.

Abcourt Closes a First Tranche of the Private Placement of Units Previously Announced, for an Amount of $1,436,234

Retrieved on: 
Tuesday, March 26, 2024
Cloud, Giant, Indian stock exchange, Control, TSX Venture Exchange, Private, Exercise, Offering, Minority, ABI, Sale, TMX Group, WIRE, News, NOT, Multilateral, NEWS, Security (finance)

ROUYN-NORANDA, Quebec, March 26, 2024 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) announces that it has completed a first closing of the non-brokered private placement announced on March 12, 2024, for gross proceeds of $1,436,234, representing 28,724,688 units of the Corporation (the “Units”), at a price of $0.05 per Unit (the "Offering"). Each Unit consists of one common share of the Corporation (a “Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at a price of $0.06 for a period of 36 months following the closing date of the Offering.

Key Points: 
  • Each Unit consists of one common share of the Corporation (a “Common Share”) and one common share purchase warrant (a “Warrant”).
  • Each Warrant entitles the holder thereof to purchase one Common Share at a price of $0.06 for a period of 36 months following the closing date of the Offering.
  • Abcourt paid finder’s fees in an amount of $500 and issued 10,000 finder warrants to Red Cloud Securities Inc., who assisted Abcourt by introducing a subscriber to the Corporation in connection with the Offering.
  • As a result, François Mestrallet will become a Control Person of the Corporation.

Houlihan Lokey Continues Expansion of Its Capital Markets Group With Senior Hire

Retrieved on: 
Monday, April 8, 2024
Finance, Consulting, Banking, Professional Services, Fintech, Private, Houlihan, Cowen Inc., Capital market, Financial services

Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Michael Schwartz has joined as a Managing Director in its Capital Markets Group.

Key Points: 
  • Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Michael Schwartz has joined as a Managing Director in its Capital Markets Group.
  • Prior to Lazard, he was a Managing Director in the Debt Capital Markets group at Cowen and Company.
  • “We are thrilled to be adding an individual of Michael’s caliber to our Capital Markets team,” said Anthony Martino, Managing Director and Global Co-Head of Houlihan Lokey’s Capital Markets Group.
  • Houlihan Lokey’s Capital Markets Group now has more than 90 dedicated finance professionals across offices in New York, Los Angeles, Chicago, Houston, Dallas, San Francisco, London, Manchester, Frankfurt, Milan, Dubai, and Paris.

ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France

Retrieved on: 
Monday, March 25, 2024
Offerings, Private, Brussels Stock Exchange, Euronext, DSM-IV codes, NOT, Euronext Amsterdam, Movement, SCI, Security (finance)

EINDHOVEN, the Netherlands, March 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD) (the “Company” or “ONWARD Medical”), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disorders, announces today the closing of its previously announced private placement with institutional investors, certain founders, certain members of management, and certain members of the Board of Directors (the “Private Placement”) and of its separate public offering via the PrimaryBid platform with retail investors in France (the “Public Offer” and together with the Private Placement the “Offerings”).  The gross proceeds from the Offerings amount to €20 million. 

Key Points: 
  • OTHER RESTRICTIONS ARE APPLICABLE.
  • PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
  • As of today, the new shares issued pursuant to the Offerings are admitted to listing and trading on Euronext Brussels and Euronext Amsterdam.
  • This press release does not constitute, contain, or form part of an offering of securities in any jurisdiction.

ThreeD Capital Inc. Announces Completion of Private Placement with Sariel Diagnostics Corp.

Retrieved on: 
Saturday, March 23, 2024
Private placement, IDK, Sariel, Private

TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia.

Key Points: 
  • TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia.
  • As a result of the Private Placement, ThreeD has acquired 3,750,000 common shares of Sariel at a price of $0.02 per share.
  • No commission or finders’ fees were paid in connection with the Private Placement.
  • All securities issued and issuable in connection with the Private Placement are subject to a statutory hold period expiring on July 23, 2024.

Major Announces Application for Partial Revocation Order

Retrieved on: 
Friday, March 22, 2024
Unit, Legislation, Private placement, Bank statement, Private, BCSC, Security (finance)

If the partial revocation order is granted, the company intends to complete a non-brokered private placement of up to thirty million units (“Units”) issued at a price of $0.025 per Unit for gross proceeds of up to $750,000.

Key Points: 
  • If the partial revocation order is granted, the company intends to complete a non-brokered private placement of up to thirty million units (“Units”) issued at a price of $0.025 per Unit for gross proceeds of up to $750,000.
  • Each Unit will be comprised of one common share (each a “Share”) and one transferable common share purchase warrant (each a “Warrant”).
  • All of the Company's securities issued in connection with the Private Placement, will remain subject to the FFCTO until such order is fully revoked.
  • The granting of the partial revocation order by the BCSC does not guarantee the issuance of a full revocation order in the future.

ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France

Retrieved on: 
Thursday, March 21, 2024
Offerings, Public, Private, Brussels Stock Exchange, KBC, Euronext, DSM-IV codes, CSO, Euronext Amsterdam, NOT, SCI, Movement, Hand, Security (finance)

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.

Key Points: 
  • PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
  • “We are delighted to announce the successful capital raise of €20 million, including a fully subscribed upsize option despite challenging market conditions,” said Dave Marver, CEO of ONWARD Medical.
  • Existing shareholders participated in the deal with an aggregate of 333,333 shares and 333,333 shares respectively allocated to INKEF Capital and EQT Life Sciences.
  • Following the Offerings, INKEF Capital and EQT Life Sciences will respectively hold 11.5% and 11.2% of the Company’s share capital.